Aging and age-related Diseases

Unravel the biological processes behind cellular and organismal decline to extend healthspan and lifespan.

Using the model organism C. elegans, Nagi Bioscience’s SydLab™ One platform offers an innovative solution designed to empower researchers in the aging field with real-time, precise insights into the effects of various interventions on aging pathways.

Accelerate and de-risk the discovery of potential interventions and therapeutics that can enhance healthspan, reduce age-related decline, and ultimately contribute to longer, healthier lives.

Explore the SydLab One platform

Explore our aging research services

Automated in vivo healthspan & lifespan at in vitro scale

Minimizing the need for vertebrate models and associated ethical concerns.

Healthspan
assessment beyond survival

Identify mechanisms of action of your genetic interventions and candidate compounds.

Cost-effective preclinical
solutions

Early in vivo testing for more accurate predictions of human outcomes.

The SydLab™ Advantage

In vivo healthspan and lifespan at the in vitro scale:

Provides a faster, more cost effective model than vertebrate testing, while remaining as efficient as cell culture models

High-throughput in vivo screening:

Speed up experiments; ensure consistency and lower costs with SydLab’s automated processes

Ethical preclinical studies:

Comprehensive in vivo / in vitro screening and higher cost effectiveness

Flexible solution:

SydLab™ One’s advanced high-content imaging of helps you analyse diverse phenotypes and supports a broad applications spectrum

High translational value:

Gain actionable, early insights through an established, human-relevant model

Real-time kinetic analysis:

Support drug mechanism analysis with SydLab™’s technology-driven healthspan and lifespan metrics

Data in Action

Readouts

Growth parameters
Reproductive parameters
Motility

Healthspan
Mean lifespan
Maximum lifespan

We are very pleased with the experience of the Nagi Bioscience team and the exceptional quality of their work. Their innovative technology has been instrumental in allowing us to gather critical scientific data quickly, providing invaluable insights that significantly advance our research in longevity.

Erez Aminov

CEO, Telomir Pharmaceuticals, Inc.

By improving precision and enhancing reproducibility, SydLab™ One empower us to explore new frontiers in critical fields of medical science. We are excited to leverage this fully automated, end-to-end solution in our projects.

Prof. Konstantinos Palikaras, PhD

Group Leader of the Unit of Neurogenetics and Ageing, Laboratory of Physiology, University of Athens (NKUA)

We have a fantastic opportunity to use this technology to generate high-throughput data, while maintaining a high resolution to uncover new insights that will drive advancements in the neurobiology of ageing.

Prof. Ellen Nollen, PhD

Group Leader of the Laboratory of Molecular Neurobiology of Ageing, European Research Institute for the Biology of Ageing (ERIBA)

We are thrilled to be part of Nagi’s Priority Access Program. Using SydLab™ One, we are enhancing natural product research by replacing manual C. elegans assays while delivering more detailed and reproducible results.

Prof. Timo H. J. Niedermeyer, PhD

Group Leader of the Pharmaceutical Biology Group, Freie Universität Berlin